Literature DB >> 16000896

Amniotic membrane use in ophthalmology.

José A P Gomes1, André Romano, Myrna S Santos, Harminder S Dua.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to describe the most recent and relevant clinical and experimental data about the use of amniotic membrane in ophthalmology. RECENT
FINDINGS: The amniotic membrane is a biologic tissue that has been used as a graft for corneal and conjunctival reconstruction in a variety of ocular surface diseases. It is avascular and possesses anti-angiogenetic, anti-scarring and antiinflammatory properties. It is not a substitute but rather a substrate upon which cells can migrate and regenerate, forming new and healthy tissue. The amniotic membrane can also be used as a biologic patch, as a bandage, to treat acute inflammatory disorders. With the development of cell therapy, amniotic membrane can be also used as a carrier of limbal stem cells or their progeny, cultivated in vitro.
SUMMARY: Amniotic membrane use in ophthalmic surgery has been shown to provide an alternative for corneal and conjunctival reconstruction in many clinically challenging situations; however, there is still a lack of scientific evidence based on randomized comparative studies to prove that its use is better than other alternative therapies for ocular surface reconstruction.

Entities:  

Mesh:

Year:  2005        PMID: 16000896     DOI: 10.1097/01.icu.0000172827.31985.3a

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  43 in total

1.  In vitro reconstruction and characterization of tissue-engineered human corneal epithelium with seeder cells from an untransfected human corneal epithelial cell line.

Authors:  Bin Xu; Ting-Jun Fan; Hong-Shou Yang; Ai Sun; Jun Zhao; Xi-Ya Ma; Xiu-Zhong Hu
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 2.  Amnion-derived pluripotent/multipotent stem cells.

Authors:  Toshio Miki; Stephen C Strom
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

3.  Amniotic membrane-covered bio-onlays for treatment of ocular surface disease.

Authors:  C Cursiefen; C Rummelt; M W Beckmann; F E Kruse
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

Review 4.  Epithelial stem cells of the eye surface.

Authors:  R P Revoltella; S Papini; A Rosellini; M Michelini
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

5.  Placenta-derived stem cells: new hope for cell therapy?

Authors:  Marco Evangelista; Maddalena Soncini; Ornella Parolini
Journal:  Cytotechnology       Date:  2008-09-28       Impact factor: 2.058

6.  Long-term symptomatic relief of bullous keratopathy with amniotic membrane transplant.

Authors:  Gillian D J Y Siu; Alvin L Young; Lulu L Cheng
Journal:  Int Ophthalmol       Date:  2015-01-14       Impact factor: 2.031

7.  Systematic review and meta-analysis investigating autograft versus allograft cultivated limbal epithelial transplantation in limbal stem cell deficiency.

Authors:  Mohammad Amir Mishan; Mehdi Yaseri; Alireza Baradaran-Rafii; Mozhgan Rezaei Kanavi
Journal:  Int Ophthalmol       Date:  2019-03-02       Impact factor: 2.031

8.  Surgical management of corneal limbal dermoids: retrospective study of different techniques and use of Mitomycin C.

Authors:  S J Lang; D Böhringer; T Reinhard
Journal:  Eye (Lond)       Date:  2014-05-23       Impact factor: 3.775

Review 9.  [Ocular surface reconstruction in limbal stem cell insufficiency: transplantation of limbal tissue].

Authors:  P Eberwein; T Reinhard
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

10.  Limbal stem cell transplantation: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2008-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.